Quagen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QUAGEN, and what generic and branded alternatives to QUAGEN drugs are available?
QUAGEN has twenty-four approved drugs.
Drugs and US Patents for Quagen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Quagen | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | SOLUTION;ORAL | 213567-001 | Jun 4, 2020 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Quagen | BUTALBITAL AND ACETAMINOPHEN | acetaminophen; butalbital | TABLET;ORAL | 214305-001 | Feb 1, 2024 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Quagen | HALOBETASOL PROPIONATE | halobetasol propionate | OINTMENT;TOPICAL | 213560-001 | Oct 6, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.